In this edition of Device Week, Medtech Insight’s Marion Webb discusses the huge number of digital health deals being done at the moment, including exciting developments in the SPAC space. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics.

- Exec Chat: Pear Therapeutics’ CEO Charts Future For Digital Therapeutics Following SPAC Deal - https://medtech.pharmaintelligence.informa.com/MT144127/Exec-Chat-Pear-Therapeutics-CEO-Charts-Future-For-Digital-Therapeutics-Following-SPAC-Deal

- HeartFlow Wants To Accelerate Adoption Of AI-Powered Heart Disease Test With $2.4Bn SPAC Deal - https://medtech.pharmaintelligence.informa.com/MT144222/HeartFlow-Wants-To-Accelerate-Adoption-Of-AIPowered-Heart-Disease-Test-With-24Bn-SPAC-Deal

- Angle Will Reshape Liquid Diagnostics By Capturing Circulating Tumor Cells -

https://medtech.pharmaintelligence.informa.com/MT144198/Angle-Will-Reshape-Liquid-Diagnostics-By-Capturing-Circulating-Tumor-Cells